Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study

…, P Makalo, EAN Aryee, NDE Alexander, A Sillah… - The Lancet, 2005 - thelancet.com
Background Community-wide mass antibiotic treatment is a central component of trachoma
control. The optimum frequency and duration of treatment are unknown. We measured the …

[HTML][HTML] Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial

…, B Munoz, MJ Holland, SE Burr, A Sillah… - PLoS neglected …, 2010 - journals.plos.org
Background Blinding trachoma, caused by ocular infection with Chlamydia trachomatis, is
targeted for global elimination by 2020. Knowledge of risk factors can help target control …

[HTML][HTML] Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia

EM Harding-Esch, A Sillah, T Edwards… - PLoS neglected …, 2013 - journals.plos.org
Background The World Health Organization has recommended three rounds of mass drug
administration (MDA) with antibiotics in districts where the prevalence of follicular trachoma (…

[HTML][HTML] Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities

…, P Makalo, EAN Aryee, A Sillah… - PLoS neglected …, 2010 - journals.plos.org
Background The elimination of blinding trachoma focuses on controlling Chlamydia trachomatis
infection through mass antibiotic treatment and measures to limit transmission. As the …

[HTML][HTML] Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?

EM Harding-Esch, T Edwards, A Sillah… - PLoS neglected …, 2009 - journals.plos.org
Background Trachoma has been endemic in The Gambia for decades. National trachoma
control activities have been in place since the mid-1980's, but with no mass antibiotic …

[HTML][HTML] Trichiasis surgery in The Gambia: a 4-year prospective study

SN Rajak, P Makalo, A Sillah… - … & visual science, 2010 - iovs.arvojournals.org
Purpose.: Trachoma is the leading infectious cause of blindness. Conjunctival Chlamydia
trachomatis infection causes scarring, entropion, trichiasis, and blinding corneal opacification. …

[HTML][HTML] Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with …

…, V Perreten, J Hart, EM Harding-Esch, A Sillah… - BMC microbiology, 2017 - Springer
Background Mass drug administration (MDA) with azithromycin is a corner-stone of trachoma
control however it may drive the emergence of antimicrobial resistance. In a cluster-…

[HTML][HTML] Operational comparison of single-dose azithromycin and topical tetracycline for trachoma

RJC Bowman, A Sillah, C van Dehn… - … & visual science, 2000 - iovs.arvojournals.org
purpose. World Health Organization guidelines for antibiotic treatment of trachoma currently
include a 6-week course of tetracycline eye ointment twice daily or a single dose of oral …

[HTML][HTML] Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia

…, SK West, DCW Mabey, A Sillah… - PLoS neglected …, 2013 - journals.plos.org
Background Trachoma, caused by ocular Chlamydia trachomatis infection, is the leading
infectious cause of blindess, but its prevalence is now falling in many countries. As the …

[HTML][HTML] Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia

…, MJ Holland, DCW Mabey, A Sillah… - Bulletin of the World …, 2014 - SciELO Public Health
Objective To evaluate the effect of repeated mass drug administration (MDA) of azithromycin
in the Gambia on the nasopharyngeal carriage of Streptococcus pneumoniae and on the …